The World Health Organisation said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.
Published : 17 Jun 2020, 11:16 PM
"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.